Home
Search
Events

BIO CEO & Investor Conference

February 14-17, 2022
CEO Covid Banner


2022 BIO CEO & Investor Conference: Hybrid Event


For more than 20 years, the BIO CEO & Investor Conference has fueled the biotech industry networking with premier investor and banking communities, focused on established and emerging publicly traded and select private biotech companies. 

The BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies, where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry.

 

Thank You to Our 2022 Sponsors
View All Sponsors
Engage in Meaningful Discussions and Critical Programming on:
Policy

Implications of Biden administration healthcare policy initiatives on biotech

Business

ESG investor expectations as well as IPO, M&A, and SPAC trends

Innovation

Therapeutic frontiers
 

ceoingfographic
Health & Safety

BIO is committed to your safety. Please review the latest updates to our health and safety protocols.

View Health & Safety Protocols
View FAQs
Committee Meeting
2022 Advisory Committee

This esteemed group of institutional investors, industry analysts, and senior biotechnology executives helped shape the 2022 program.

See 2022 Advisory Committee
BIO2020_CompanyPresentations-1
Company Presentations

Company Presentations are an integral programming element at BIO CEO & Investor Digital Conference that allow companies to discuss their pipeline, R&D activities, and future fundraising goals to this exclusive audience of investors and collaboration partners.

Learn More
Subscribe to BIO CEO & Investor Conference

Subscribe to BIO CEO & Investor Conference and receive timely event updates, exclusive content, partnering and programming announcements, and more.

Add Me to the Mailing List